Many decks talk about “reg risk” and “reimbursement” in a single bullet.
This piece goes deeper:
* How to test “What do regulators think you are?”
* Why coding, coverage, and payment must be separate conversations
* How policy (like orphan incentives or DME categories) can turn path risk into upside